Xuanlong Du
Nanjing, 210009, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
O-GlcNAcylated RALY Contributes to Hepatocellular Carcinoma Cells Proliferation by Regulating USP22 mRNA Nuclear Export.
Journal: International journal of biological sciences
Published: April 16, 2024
Targeting Reprogrammed Cancer-Associated Fibroblasts with Engineered Mesenchymal Stem Cell Extracellular Vesicles for Pancreatic Cancer Treatment.
Journal: Biomaterials research
Published: December 20, 2023
Engineered extracellular vesicles for targeted reprogramming of cancer-associated fibroblasts to potentiate therapy of pancreatic cancer.
Journal: Signal transduction and targeted therapy
Published: October 01, 2023
Multifunctional Nanoplatform Based on Sunitinib for Synergistic Phototherapy and Molecular Targeted Therapy of Hepatocellular Carcinoma.
Journal: Micromachines
Published: January 17, 2023
Downregulated liver-elevated long intergenic noncoding RNA (LINC02428) is a tumor suppressor that blocks KDM5B/IGF2BP1 positive feedback loop in hepatocellular carcinoma.
Journal: Cell death & disease
Published: December 13, 2022
Risk factors and predictive nomograms for early death of patients with pancreatic cancer liver metastasis: A large cohort study based on the SEER database and Chinese population.
Journal: Frontiers in oncology
Published: July 20, 2022
RAB6B is a potential prognostic marker and correlated with the remolding of tumor immune microenvironment in hepatocellular carcinoma.
Journal: Frontiers in pharmacology
Published: July 08, 2022
RAB42 is a Potential Biomarker that Correlates With Immune Infiltration in Hepatocellular Carcinoma.
RAB42 is a Potential Biomarker that Correlates With Immune Infiltration in Hepatocellular Carcinoma.
Journal: Frontiers in molecular biosciences
Published: March 17, 2022
Risk factors and predictive nomograms for early death of patients with advanced hepatocellular carcinoma: a large retrospective study based on the SEER database.
Journal: BMC gastroenterology
Published: March 03, 2022
Emerging treatment modalities for systemic therapy in hepatocellular carcinoma.
Journal: Biomarker research
Published: May 22, 2021
Integrated Analysis of Immunity- and Ferroptosis-Related Biomarker Signatures to Improve the Prognosis Prediction of Hepatocellular Carcinoma.
Journal: Frontiers in genetics
Published: October 09, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026